Denis Alipov, Russia’s envoy to India, stated on Friday that Indian pharmaceutical companies might fill the demand for Western pharmaceutical companies in Russia.
As a result of Russia’s invasion of Ukraine, the West has slapped a number of sanctions on the country. The crisis began on February 24, when Russian President Vladimir Putin ordered a military strike against the country in Eastern Europe. In the midst of the Russia-Ukraine war, Alipov claimed earlier this month that Moscow has embraced India’s autonomous foreign policy.
“In several areas, including medicines, the withdrawal of numerous Western corporations from the Russian market and the niches that have been deserted may actually be taken by Indian enterprises,” Alipov told the Rossiya 24 channel, as quoted by Sputnik news agency.
India is a “global pharmacy” and a major manufacturer of medication duplicates that are no worse than the original, according to Alipov, who was recently chosen as Russia’s envoy to India.
Last year, India’s Vaccine Maitri project solidified its position as the world’s “pharmacy.” At important junctures in the pandemic, world leaders publicly praised India’s efforts to swiftly expand vaccine production and supplies.
This decision to change pharmaceutical makers comes at a time when Russia is facing sanctions from Western countries. Russia is now aiming to expand its economic ties with non-European countries.
In response to a question about India’s ties, Alipov stated, “The Prime Minister (Modi) and the Indian leadership adhere to the state’s persistent independent foreign policy. We have indicated repeatedly that we support India’s autonomous foreign policy and its efforts to increase its role and influence in the international arena.”
The Russian envoy also praised India’s foreign policy position on the current crisis between Russia and Ukraine.
